In addition to IL-6, IL-8 has been shown to play significant roles in predicting the efficacy of ICIs in advanced HCC, primarily through its role in promoting resistance via recruitment of myeloid-derived suppressor cells [49,50,51]. Here, IL6 is linked to hepatocellular carcinoma.